Mike Nerenberg

Company: Exagen

Job title: Chief Medical Officer

Seminars:

A Blood-Based Protein Index for Earlier Assessment of Kidney Damage 12:30 pm

Exagen has developed a 4-protein index for detection of kidney damage from plasma It was guided by set of proprietary rules for protein selection, which accelerated development The index was shown to outperform serum creatine and eGFR in cohorts of kidney disease associated with Diabetic (N=100) or Lupus Nephropathy (N=31), yielding AUCs of 0.91 and…Read more

day: Day One Track 1 AM